These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 22581233)
1. Therapeutic targeting of oncogenic transforming growth factor-β1 signaling by antisense oligonucleotides in oral squamous cell carcinoma. Kim SG; Song JY Oncol Rep; 2012 Aug; 28(2):539-44. PubMed ID: 22581233 [TBL] [Abstract][Full Text] [Related]
2. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4. Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607 [TBL] [Abstract][Full Text] [Related]
3. [Effect of decorin gene transfection on human gastric carcinoma xenograft growth in nude mice]. Liu B; Jiang Z; Wang C; Hu ZM; Ji W; Cai C; Kang YJ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1009-12. PubMed ID: 23046927 [TBL] [Abstract][Full Text] [Related]
5. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts. Bran GM; Goessler UR; Baftiri A; Hormann K; Riedel F; Sadick H Otolaryngol Head Neck Surg; 2010 Jul; 143(1):66-71. PubMed ID: 20620621 [TBL] [Abstract][Full Text] [Related]
6. Antitumor mechanisms of systemically administered epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Thomas SM; Ogagan MJ; Freilino ML; Strychor S; Walsh DR; Gooding WE; Grandis JR; Zamboni WC Mol Pharmacol; 2008 Mar; 73(3):627-38. PubMed ID: 18025070 [TBL] [Abstract][Full Text] [Related]
7. [Effect of PCNA antisense oligooxynucleotides and VEGF antisense oligoxynucleotides on growth of hepatocellular carcinoma transplanted in nude mice]. Zhu J; Huang J; Chen Y Zhonghua Wai Ke Za Zhi; 2001 Nov; 39(11):875-7. PubMed ID: 11930748 [TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo. Marzo AL; Fitzpatrick DR; Robinson BW; Scott B Cancer Res; 1997 Aug; 57(15):3200-7. PubMed ID: 9242450 [TBL] [Abstract][Full Text] [Related]
9. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis. Boirivant M; Pallone F; Di Giacinto C; Fina D; Monteleone I; Marinaro M; Caruso R; Colantoni A; Palmieri G; Sanchez M; Strober W; MacDonald TT; Monteleone G Gastroenterology; 2006 Dec; 131(6):1786-98. PubMed ID: 17087939 [TBL] [Abstract][Full Text] [Related]
11. Effect of TGF-beta1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats. Hiong LC; Voon KL; Abdullah NA; Sattar MA; Rahman NA; Khan AH; Johns EJ Acta Pharmacol Sin; 2008 Apr; 29(4):451-7. PubMed ID: 18358091 [TBL] [Abstract][Full Text] [Related]
12. Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway. Shibata S; Marushima H; Asakura T; Matsuura T; Eda H; Aoki K; Matsudaira H; Ueda K; Ohkawa K Int J Oncol; 2009 May; 34(5):1433-48. PubMed ID: 19360357 [TBL] [Abstract][Full Text] [Related]
13. Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-beta 1 secreted by the tumor cells. Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK J Cell Biochem; 2006 Apr; 97(5):1036-51. PubMed ID: 16294321 [TBL] [Abstract][Full Text] [Related]
14. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma. Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283 [TBL] [Abstract][Full Text] [Related]
15. Abrogation of transforming growth factor-beta type II receptor stimulates embryonic mouse lung branching morphogenesis in culture. Zhao J; Bu D; Lee M; Slavkin HC; Hall FL; Warburton D Dev Biol; 1996 Nov; 180(1):242-57. PubMed ID: 8948588 [TBL] [Abstract][Full Text] [Related]
16. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice. Xu W; Wang LW; Shi JZ; Gong ZJ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172 [TBL] [Abstract][Full Text] [Related]
17. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Moore LD; Isayeva T; Siegal GP; Ponnazhagan S Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of transforming growth factor type III receptor restores TGF-β1 sensitivity in human tongue squamous cell carcinoma cells. Li D; Xu D; Lu Z; Dong X; Wang X Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26205654 [TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169 [TBL] [Abstract][Full Text] [Related]
20. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice]. Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]